From Genetic Tests to Tailored Care: Decoding a field with big potential -- and even bigger implications
By Kelly Bothum,
Delaware Online
| 06. 01. 2010
[Quotes CGS's Jesse Reynolds]
Imagine a doctor using your genetic profile to decide which medicine to prescribe or to determine your risk for developing a life-threatening health problem. It's not a medical fantasy -- genetic tests already are used to gauge how patients will respond to certain drugs or to look for mutations in specific genes that can increase the risk for developing aggressive types of cancer.
But while the potential of so-called personalized medicine seems immense, some big questions are years away from being fully answered. Right now, researchers are still trying to understand key issues related to this next frontier of modern medicine, including how genetic profiling can help patients better understand their health risks, how medical professionals will be able to interpret results and what, if any, ethical implications arise in having this much genetic information.
"Personalized medicine is still in its infancy," said Dr. Ayyappan Rajasekaran, director of the Nemours Center for Childhood Cancer Research, which is studying biomarkers that can help identify more aggressive forms of the disease in kids. "We have a chance to do fantastic work."
At...
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
By Pam Belluck, The New York Times | 10.17.2025
Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
By Deni Ellis Béchard, The Washington Post | 10.07.2025
In 1949, when John Gurdon was a 16-year-old boarding school student at Eton College in England, his teacher described his biology studies as “disastrous” and his scientific ambitions as “ridiculous.”
“If he can’t learn simple biological facts,” his term report...